240 related articles for article (PubMed ID: 36869348)
1. The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature.
Da'as SI; Ahmed I; Hasan WH; Abdelrahman DA; Aliyev E; Nisar S; Bhat AA; Joglekar MV; Hardikar AA; Fakhro KA; Akil ASA
J Transl Med; 2023 Mar; 21(1):171. PubMed ID: 36869348
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148a-3p alleviates high glucose-induced diabetic retinopathy by targeting TGFB2 and FGF2.
Wang J; Yao Y; Wang K; Li J; Chu T; Shen H
Acta Diabetol; 2020 Dec; 57(12):1435-1443. PubMed ID: 32661705
[TBL] [Abstract][Full Text] [Related]
3. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
Han N; Tian W; Yu N; Yu L
J Cell Physiol; 2020 Feb; 235(2):1309-1320. PubMed ID: 31313295
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
5. Serum exosomal miR-377-3p inhibits retinal pigment epithelium proliferation and offers a biomarker for diabetic macular edema.
Jiang L; Cao H; Deng T; Yang M; Meng T; Yang H; Luo X
J Int Med Res; 2021 Apr; 49(4):3000605211002975. PubMed ID: 33906524
[TBL] [Abstract][Full Text] [Related]
6. MiR-221-3p regulates the microvascular dysfunction in diabetic retinopathy by targeting TIMP3.
Wang C; Lin Y; Fu Y; Zhang D; Xin Y
Pflugers Arch; 2020 Nov; 472(11):1607-1618. PubMed ID: 32648125
[TBL] [Abstract][Full Text] [Related]
7. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study.
Al-Rawaf HA; Alghadir AH; Gabr SA
Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy.
Torus B; Korkmaz H; Ozturk KH; Şirin FB; Argun M; Şevik S; Tök L
Minerva Endocrinol (Torino); 2023 Mar; 48(1):42-50. PubMed ID: 33213115
[TBL] [Abstract][Full Text] [Related]
9. Highly-Expressed MiR-221-3p Distinctly Increases the Incidence of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
Zhao L; Pan Q
Transl Vis Sci Technol; 2023 Oct; 12(10):17. PubMed ID: 37856104
[TBL] [Abstract][Full Text] [Related]
10. Plasma Levels and Diagnostic Significance of miR-335-3p and EGFR in Diabetic Retinopathy.
Xia Z; Yang X; Zheng Y; Yi G; Wu S
Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443588
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Expression in the Aqueous Humor of Patients with Diabetic Macular Edema.
Grieco GE; Sebastiani G; Eandi CM; Neri G; Nigi L; Brusco N; D'Aurizio R; Posarelli M; Bacci T; Benedetto E; Fruschelli M; Orlandini M; Galvagni F; Dotta F; Tosi GM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023063
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-425-5p Is Involved in the Development of Diabetic Retinopathy and Regulates the Proliferation and Migration of Retinal Microvascular Endothelial Cells.
Liu X; Zhou Y; Liu Y; Wang Q; Pan L
Ophthalmic Res; 2022; 65(1):60-67. PubMed ID: 34571504
[TBL] [Abstract][Full Text] [Related]
13. Whole blood microRNA levels associate with glycemic status and correlate with target mRNAs in pathways important to type 2 diabetes.
Mononen N; Lyytikäinen LP; Seppälä I; Mishra PP; Juonala M; Waldenberger M; Klopp N; Illig T; Leiviskä J; Loo BM; Laaksonen R; Oksala N; Kähönen M; Hutri-Kähönen N; Raitakari O; Lehtimäki T; Raitoharju E
Sci Rep; 2019 Jun; 9(1):8887. PubMed ID: 31222113
[TBL] [Abstract][Full Text] [Related]
14. Plasma
Jiang Q; Lyu XM; Yuan Y; Wang L
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108673
[TBL] [Abstract][Full Text] [Related]
15. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-29b-3p Promotes Human Retinal Microvascular Endothelial Cell Apoptosis via Blocking SIRT1 in Diabetic Retinopathy.
Zeng Y; Cui Z; Liu J; Chen J; Tang S
Front Physiol; 2019; 10():1621. PubMed ID: 32063865
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.
Xia F; Sun JJ; Jiang YQ; Li CF
J Cell Physiol; 2018 Jan; 234(1):721-730. PubMed ID: 30191948
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of miR-21-3p, miR-30b-5p and miR-150-5p shuttled by extracellular vesicles from diabetic subjects reveals their association with diabetic retinopathy.
Mazzeo A; Lopatina T; Gai C; Trento M; Porta M; Beltramo E
Exp Eye Res; 2019 Jul; 184():56-63. PubMed ID: 31002820
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy.
Greco M; Chiefari E; Accattato F; Corigliano DM; Arcidiacono B; Mirabelli M; Liguori R; Brunetti FS; Pullano SA; Scorcia V; Fiorillo AS; Foti DP; Brunetti A
Front Endocrinol (Lausanne); 2020; 11():528. PubMed ID: 32849308
[No Abstract] [Full Text] [Related]
20. MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction.
Silambarasan M; Tan JR; Karolina DS; Armugam A; Kaur C; Jeyaseelan K
Int J Mol Sci; 2016 Apr; 17(4):518. PubMed ID: 27070575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
